Skip to content
CancerIndex

Publication

Clinicopathological analysis of 110 cases of SMARCA4-deficient conventional non-small cell lung cancer.

Huifang Li, Diming Wang, Jian Zhao, Jieting Zhao, Rongrong Song, Xianfeng Shi, Wenwen Lv, Xiaoliang Shi, Congcong Song, Xiaodong Zhu, Wei Ye

Annals of diagnostic pathologyDec 1, 2026PMID 42664756doi:10.1016/j.anndiagpath.2026.152708 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 19, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260919-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

SMARCA4-deficient conventional non-small cell lung carcinoma (SMARCA4-dNSCLC) is an aggressive NSCLC subtype with significant phenotypic heterogeneity. We retrospectively examined 110 SMARCA4-dNSCLC patients diagnosed between July 2022 and February 2025, focusing on TTF-1 and P40 expression…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.